HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Family study of acute intermittent porphyria and hereditary coproporphyria in Niigata and Akita Prefectures, Japan.

Abstract
Simple screening tests, urinary porphobilinogen (PBG) for acute intermittent porphyria (AIP) and fecal coproporphyrin for hereditary coproporphyria (HCP), were performed in a family study of AIP and HCP. Urinary PBG was positive in 93 of 211 members of 10 AIP families, but was negative in 568 of 572 controls. Fecal coproporphyrin was positive in 54 of 108 members of 10 HCP families, but was negative in 188 controls. A dominant inheritance was assumed by a chi-square test and Weinberg segregation ratio. Worsening factors around puberty were suggested by the onset age and cumulative percentage of genetically loaded cases. Sex-related expression of symptoms was also inferred by a higher incidence of both porphyrias in females than in males. Fitness and penetrance of both porphyrias were good. An l-triiodothyronine loading test was the most useful for the detection of masked carriers of AIP. In conclusion, AIP and HCP in Japan show a dominant inheritance with sex-related metabolic and clinical manifestations.
AuthorsH Sasaki, K Kaneko, H Tsuneyama, M Daimon, K Yamatani, H Manaka
JournalJournal of clinical epidemiology (J Clin Epidemiol) Vol. 49 Issue 10 Pg. 1117-23 (Oct 1996) ISSN: 0895-4356 [Print] United States
PMID8826991 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Coproporphyrins
  • Porphobilinogen
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers
  • Child
  • Coproporphyrins (analysis)
  • Feces (chemistry)
  • Female
  • Humans
  • Japan (epidemiology)
  • Male
  • Middle Aged
  • Pedigree
  • Porphobilinogen (urine)
  • Porphyria, Acute Intermittent (ethnology, genetics)
  • Porphyrias, Hepatic (ethnology, genetics)
  • Sex Characteristics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: